ArticleCurrent oncology (Toronto, Ont.)2022

Safety Related to the Timing of Radiotherapy and Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Single Institutional Experience.

Michael C Tjong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.